Differences in efficacy between brand-name and generic suxamethonium in modified electroconvulsive therapy: a retrospective observational study

Association between brand-name or generic suxamethonium for modified electroconvulsive therapy and muscle relaxation: comparative effectiveness study - Association between brand-name or generic suxamethonium for modified electroconvulsive therapy and muscle relaxation: comparative effectiveness study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050713

Enrollment

300

Registered

2023-03-29

Start date

2023-03-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases that require modified ECT for treatment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Psychiatric patients undergoing modified electroconvulsive therapy

Exclusion criteria

Exclusion criteria: Patients with contraindications to succinylcholine administration, patients with malignant syndromes, patients with a history or family history of malignant hyperthermia, and other patients for whom succinylcholine administration is considered contraindicated

Design outcomes

Primary

Measure	Time frame
Ease of oral protector insertion is divided into three levels: excellent, good, or poor.	—

Secondary

Measure	Time frame
Complications, etc.	—

Countries

Japan

Contacts

Public ContactMizuho Matsui

Seijin Hospital Medical office

ryosoclinic@gmail.com050-3734-5401

Outcome results